Business
Promising antibody response in Australians given Novavax COVID-19 vaccine – Sydney Morning Herald
An early-stage trial of a promising COVID-19 vaccine found high levels of coronavirus-neutralising antibodies in Australians who volunteered to get the experimental injection.
Participants who received two doses of the vaccine three weeks apart had neutralising antibody levels roughly four times higher than a group of 32 patients who had recovered from COVID-19.
“We are extremely excited,” Novavax research chief Gregory Glenn said.
“At this point, it looks extremely promising … We have a technology that is extremely good at inducing functional immunity….
Continue Reading
